Literature DB >> 12240505

Imiquimod (Aldara): modifying the immune response.

Sherrill Jantzi Rudy1.   

Abstract

Imiquimod 5% cream represents a new class of topically applied immune response modifiers that are capable of enhancing immune function. It stimulates both the innate arm of the immune system as well as cell-mediated immunity. It is currently indicated for treating genital human papilloma virus infection. However, because of its action on the immune system it shows promise for wide applicability in treating other viral skin infections as well as neoplastic and immune-mediated diseases of the skin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240505

Source DB:  PubMed          Journal:  Dermatol Nurs        ISSN: 1060-3441


  3 in total

1.  Keloids: pathogenesis, clinical features, and management.

Authors:  Chuma J Chike-Obi; Patrick D Cole; Anthony E Brissett
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

2.  Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research.

Authors:  Yu-Jei Lin; Tsung-Lin Lee; Chia-Chi Ku
Journal:  J Vis Exp       Date:  2017-04-19       Impact factor: 1.355

3.  Evaluation of the Effect of Morphine and Imiquimodon Expression of TLR2 and TLR4 from Lesion RNA Extracted from BALB/c Mice Infected with Leishmania major.

Authors:  Parisa Ebrahimisadr; Fatemeh Ghaffarifar; John Horton; Abdolhossein Dalimi; Zohreh Sharifi
Journal:  Avicenna J Med Biotechnol       Date:  2019 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.